Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

04 janv. 2016 08h00 HE | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at the 3rd Annual Dermatology Summit Meeting

REHOVOT, Israel and BRIDGEWATER, N.J., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
03 déc. 2015 07h00 HE | Source: Foamix, Ltd.

Foamix Announces Positive Top-Line Results From Phase II Study for FDX104 (Doxycycline Foam) in the Prevention of Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers

FDX104 prevented the development of moderate-to-severe antibody-induced rash in the majority of cases. FDX104 appears safe and was well-tolerated. REHOVOT, Israel and BRIDGEWATER, N.J.,...
02 déc. 2015 16h01 HE | Source: Foamix, Ltd.

Foamix to Host Conference Call & Webcast to Discuss Topline Results From Phase 2 Study of FDX-104 in Acneiform Rash Associated With Targeted Antibody Treatments for Colon and Head and Neck Cancers

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing...
01 déc. 2015 08h00 HE | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at the Oppenheimer 26th Annual Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused...
11 nov. 2015 08h00 HE | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at Jefferies Autumn 2015 Global Healthcare Conference in London

REHOVOT, Israel and BRIDGEWATER, N.J., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
11 nov. 2015 07h00 HE | Source: Foamix, Ltd.

Foamix Reports Third Quarter 2015 Financial Results and Provides Business Update

REHOVOT, Israel, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...
27 oct. 2015 13h00 HE | Source: Foamix, Ltd.

Foamix Pharmaceuticals Third Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, November 11

REHOVOT, Israel, and BRIDGEWATER, N.J., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
20 oct. 2015 08h00 HE | Source: Foamix, Ltd.

Foamix Announces Enrollment of First Patient in Phase 2 Clinical Trial of FMX103 in Papulopustular Rosacea

REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...
19 août 2015 16h01 HE | Source: Foamix, Ltd.

Foamix Reports Second Quarter 2015 Financial Results and Provides Business Update

REHOVOT, Israel, Aug. 19, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company focused on developing and...
13 août 2015 08h00 HE | Source: Foamix, Ltd.

Foamix Pharmaceuticals Second Quarter 2015 Conference Call & Webcast Scheduled for Thursday, August 20

REHOVOT, Israel and BRIDGEWATER, N.J., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), ("Foamix Pharmaceuticals"), a clinical stage specialty pharmaceutical company...

Page précédente

Page suivante